Trial reportAmerican journal of respiratory and critical care medicine2025
Dual α
Abstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph
Trial report in American journal of respiratory and critical care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Article
- Advances in pharmacotherapy for fibrotic interstitial lung disease.Medical review (2021) · 2026Review
- Collagen-binding ⁶⁸Ga-CBP8 PET/MR in Deep Pelvic Endometriosis: First-in-human Application.Molecular imaging and biology · 2026Article
- Novel biomarker of fibrosis in SSc-ILD.RMD open · 2026Article
- Disease Mechanisms and Therapeutic Advances in Idiopathic and Progressive Pulmonary Fibrosis: From Approved Drugs to Emerging Strategies.Journal of clinical medicine · 2026Review
- Peptide Angio-3 Attenuates Pulmonary Fibrosis Via Modulation of the Coagulation Factor Xa-Protease-Activated Receptor-1 Signaling Axis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
- Fibroblast activation protein inhibitor (FAPI) PET imaging in pulmonary fibrosis: pathophysiology, clinical utility, and emerging theranostic applications.Respiratory research · 2026Review
- Tweaking the Complex Fibrogenic Role of Lymphocytes in Idiopathic Pulmonary Fibrosis.Tuberculosis and respiratory diseases · 2026Article
- Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies.Signal transduction and targeted therapy · 2026Review
- Targeting Itga8 Mitigates Neurogenic Bladder Fibrosis Driven by Trem2⁺ Macrophage-Derived Fn1 via FAK/RhoA/ROCK Signaling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Multidimensional lung imaging: integrated preclinical platforms enabling the identification of translational biomarkers for pulmonary research.Respiratory research · 2026Review
- Collagen Imaging in Human Intracranial Aneurysms - a Translational Proof-of-Concept Study.Translational stroke research · 2026Article
- The importance of mechanical forces in chronic respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- A Narrative Review of Salivary Gland Extracellular Matrix and Sjögren's Syndrome: Research Status and Future Prospects.Biomolecules · 2026Review
- Integrated single-cell TCR analysis across tissue identifies GZMKInternational journal of biological sciences · 2026Article
- Chest Imaging with a Collagen-Binding Probe-A Human Hydroxyproline Assay?American journal of respiratory and critical care medicine · 2025Article
- LangerinClinical, cosmetic and investigational dermatology · 2025Review
Corrections and comments
- Commented on by
Authors and funding
13 authors.
Sydney B MontesiDivison of Pulmonary and Critical Care Medicine and.
Gregory P CosgrovePliant Therapeutics, Inc., South San Francisco, California.
Scott M TurnerFormer employee of Pliant Therapeutics, Inc., South San Francisco, California; and.
Iris Y ZhouInstitute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Nikos EfthimiouHarvard Medical School, Boston, Massachusetts.ORCID 0000-0003-1947-5033
Antonia SusnjarHarvard Medical School, Boston, Massachusetts.
Ciprian CatanaInstitute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-3249-5971
Caroline FromsonDivison of Pulmonary and Critical Care Medicine and.
Annie ClarkPliant Therapeutics, Inc., South San Francisco, California.
Martin DecarisPliant Therapeutics, Inc., South San Francisco, California.
Chris N BarnesPliant Therapeutics, Inc., South San Francisco, California.
Éric A LefebvrePliant Therapeutics, Inc., South San Francisco, California.
Peter CaravanInstitute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.
Funding
PET-MR Imaging of pulmonary fibrosisR01HL153606 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D, CATANA, CIPRIAN · 2021 to 2025
$4.1MVascular Leak and Outcomes in IPFK23HL150331 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MONTESI, SYDNEY · 2020 to 2024
$887kQuantitative MRI-PET Imaging of Pulmonary FibrosisK25HL148837 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ZHOU, IRIS YUWEN · 2020 to 2023
$686kInductively Coupled Plasma Mass SpectrometerS10OD032138 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2022 to 2022
$598kElectronics Upgrade for 11.7 TS10OD025234 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2018 to 2018
$595kAutomation Equipment for Human PET Radiotracer ProductionS10OD028499 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2021 to 2021
$325kNHLBI NIH HHS K23 HL150331NHLBI NIH HHS K25 HL148837NHLBI NIH HHS R01 HL153606NIH HHS S10 OD025234NIH HHS S10 OD028499NIH HHS S10 OD032138Pliant Therapeutics, Inc
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antigens, NeoplasmCollagen Type IIdiopathic Pulmonary FibrosisIntegrinsAgedDouble-Blind MethodFemaleHumansLungMaleMiddle AgedPositron-Emission TomographyTreatment OutcomeAntigens, NeoplasmCollagen Type Iintegrin alphavbeta6Integrinsbexotegrastcollagen type Ifibrotic diseaseidiopathic pulmonary fibrosispositron emission tomography imaging
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.